A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.


Journal

Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127

Informations de publication

Date de publication:
04 2019
Historique:
received: 29 09 2018
accepted: 23 12 2018
pubmed: 24 1 2019
medline: 29 8 2019
entrez: 24 1 2019
Statut: epublish

Résumé

Disseminated infections with the fungal species

Identifiants

pubmed: 30670549
pii: IAI.00731-18
doi: 10.1128/IAI.00731-18
pmc: PMC6434129
pii:
doi:

Substances chimiques

Antibodies, Fungal 0
Epitopes 0
Polysaccharides 0
glucuronoxylomannan 76082-65-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R008485/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 211241/Z/18/Z
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M014525/1
Pays : United Kingdom
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/R001472/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Microbiology. 2001 Aug;147(Pt 8):2355-2365
pubmed: 11496012
Virulence. 2019 Dec;10(1):822-831
pubmed: 29436899
Emerg Infect Dis. 2003 Feb;9(2):189-95
pubmed: 12603989
Microbiology. 2001 Apr;147(Pt 4):891-907
pubmed: 11283285
Med Mycol. 2005 Nov;43(7):603-12
pubmed: 16396245
Int J Syst Bacteriol. 1997 Apr;47(2):432-42
pubmed: 9103633
Mol Microbiol. 2007 May;64(3):771-81
pubmed: 17462022
J Immunol Methods. 1995 Jul 17;184(1):139-43
pubmed: 7622865
PLoS Pathog. 2015 Mar 12;11(3):e1004701
pubmed: 25764512
Emerg Infect Dis. 2011 Feb;17(2):193-9
pubmed: 21291588
PLoS Pathog. 2010 Jun 17;6(6):e1000945
pubmed: 20585557
mSphere. 2018 Oct 24;3(5):
pubmed: 30355668
J Bacteriol. 1979 Jul;139(1):318-9
pubmed: 378957
J Clin Microbiol. 1993 Feb;31(2):359-63
pubmed: 8432823
Eukaryot Cell. 2012 Jun;11(6):820-6
pubmed: 22544904
Cell Surf. 2018 Mar;1:15-24
pubmed: 30123851
Front Cell Infect Microbiol. 2016 Jan 06;5:101
pubmed: 26779451
mBio. 2015 Sep 01;6(5):e00868-15
pubmed: 26330512
Clin Vaccine Immunol. 2011 Aug;18(8):1292-6
pubmed: 21697342
Infect Immun. 1994 Jul;62(7):2857-64
pubmed: 8005676
Fungal Genet Biol. 2015 May;78:16-48
pubmed: 25721988
Mol Microbiol. 2009 Oct;74(1):126-138
pubmed: 19758241
Infect Immun. 1999 Jun;67(6):3096-107
pubmed: 10338526
PLoS Pathog. 2014 Aug 21;10(8):e1004285
pubmed: 25144534
Clin Diagn Lab Immunol. 1998 Mar;5(2):146-59
pubmed: 9521136
Mycopathologia. 1982 Jul 23;79(1):23-9
pubmed: 6750405
J Immunol. 2004 Dec 15;173(12):7513-20
pubmed: 15585878
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D671-4
pubmed: 15608286
Infect Immun. 1998 Oct;66(10):5027-30
pubmed: 9746613
Infect Immun. 2001 May;69(5):3398-409
pubmed: 11292763
Antimicrob Agents Chemother. 1998 Jun;42(6):1437-46
pubmed: 9624491
Infect Immun. 1987 Aug;55(8):1895-9
pubmed: 2440810
Mol Microbiol. 2002 Aug;45(3):837-49
pubmed: 12139628
Clin Diagn Lab Immunol. 2003 Sep;10(5):903-9
pubmed: 12965925
Mol Immunol. 1980 Aug;17(8):1025-32
pubmed: 6777664
PLoS Pathog. 2010 Apr 22;6(4):e1000850
pubmed: 20421942
Methods Enzymol. 1981;73(Pt B):3-46
pubmed: 7300683
mSphere. 2018 Nov 7;3(6):
pubmed: 30404928
Appl Environ Microbiol. 2003 Apr;69(4):2080-6
pubmed: 12676686
Eukaryot Cell. 2007 Aug;6(8):1464-73
pubmed: 17601878
PLoS Pathog. 2018 May 18;14(5):e1006982
pubmed: 29775480
Infect Immun. 1998 Jan;66(1):89-97
pubmed: 9423844
Infect Immun. 2004 Jun;72(6):3359-65
pubmed: 15155641
Curr Genet. 2006 May;49(5):341-50
pubmed: 16397763
FEMS Yeast Res. 2004 Sep;4(8):765-71
pubmed: 15450183
J Clin Invest. 2001 Dec;108(11):1639-48
pubmed: 11733559
Infect Immun. 2003 May;71(5):2868-75
pubmed: 12704160
Emerg Infect Dis. 2010 Feb;16(2):251-7
pubmed: 20113555
Am J Pathol. 1980 Oct;101(1):177-94
pubmed: 7004196
J Clin Invest. 1985 Aug;76(2):508-16
pubmed: 3928681
Lancet Infect Dis. 2017 Aug;17(8):873-881
pubmed: 28483415
mBio. 2018 Oct 23;9(5):
pubmed: 30352938
Infect Immun. 2012 Nov;80(11):3776-85
pubmed: 22890995
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17258-63
pubmed: 15572442
Eukaryot Cell. 2004 Dec;3(6):1513-24
pubmed: 15590825
Infect Immun. 1994 Sep;62(9):3864-72
pubmed: 8063403
Clin Infect Dis. 2011 Dec;53(12):1188-95
pubmed: 22016503
PLoS Pathog. 2011 Sep;7(9):e1002205
pubmed: 21909264
Infect Immun. 2001 Jan;69(1):115-22
pubmed: 11119496
PLoS Pathog. 2010 Jun 17;6(6):e1000953
pubmed: 20585559
PLoS Pathog. 2018 May 18;14(5):e1006978
pubmed: 29775474
J Exp Med. 1970 Aug 1;132(2):211-50
pubmed: 5508247
Mol Microbiol. 2001 Oct;42(2):453-67
pubmed: 11703667
Future Microbiol. 2015;10(4):565-81
pubmed: 25865194
J Infect Dis. 1992 Jun;165(6):1086-93
pubmed: 1583327
Am J Pathol. 2005 Feb;166(2):421-32
pubmed: 15681826
Infect Immun. 1992 Nov;60(11):4534-41
pubmed: 1398966
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W597-600
pubmed: 23671338
PLoS Pathog. 2018 May 18;14(5):e1007007
pubmed: 29775477
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
Virulence. 2015;6(6):652-7
pubmed: 26132337
Trends Microbiol. 2006 Nov;14(11):497-505
pubmed: 16996739

Auteurs

Mark Probert (M)

Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

Xin Zhou (X)

Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

Margaret Goodall (M)

Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

Simon A Johnston (SA)

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
Bateson Centre, University of Sheffield, Sheffield, United Kingdom.

Ewa Bielska (E)

Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

Elizabeth R Ballou (ER)

Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, United Kingdom e.r.ballou@bham.ac.uk r.c.may@bham.ac.uk.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

Robin C May (RC)

Institute of Microbiology and Infection, University of Birmingham, Edgbaston, Birmingham, United Kingdom e.r.ballou@bham.ac.uk r.c.may@bham.ac.uk.
School of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH